A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Dolutegravir Sodium Tablets (DTG)
Clinical trial NCT07002229 · COMPLETED
Trial details
- NCT number
- NCT07002229
- Sponsor
- Henan Genuine Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-09
- Primary completion
- 2022-02-23
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.